A Phase II, Randomized, Controlled Trial of The Safety and Efficacy of S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate (SAMe) in Reducing Serum Alpha-Fetoprotein (AFP) in Patients With Hepatitis C and Moderately Elevated AFP
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ademetionine (Primary)
- Indications Liver cancer
- Focus Biomarker; Therapeutic Use
- 10 Aug 2018 Biomarkers information updated
- 07 Feb 2013 Planned number of patients changed from 100 to 110 as reported by ClinicalTrials.gov.
- 14 Mar 2012 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov record.